1. Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU

   • Emma D. Deeks
   • Katherine A. Lyseng-Williamson
   • Yahiya Y. Syed

   Adis Drug Q&A 14 March 2017 Pages: 153 - 159

2. Pixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its use

   • Gillian M. Keating
   • Katherine A. Lyseng-Williamson

   Adis Drug Q&A 10 March 2017 Pages: 160 - 166

   

3. Nivolumab in previously treated patients with advanced renal cell carcinoma: a guide to its use

   • Karly P. Garnock-Jones
   • Katherine A. Lyseng-Williamson

   Adis Drug Q&A 08 February 2017 Pages: 167 - 173

   

4. Laxatives, targeted therapy and lubiprostone are options when individualizing treatment for opioid-induced constipation in the elderly

   • Adis Medical Writers

   Disease Management 07 March 2017 Pages: 174 - 180

   

5. First reports of adverse drug reactions

   Drug Reactions and Interactions 06 March 2017 Pages: 181 - 182

6. Overcoming barriers to medication adherence in bipolar disorder: a review of the role of psychosocial and medication-related interventions

   • Adis Medical Writers

   Practical Issues and Updates 03 February 2017 Pages: 183 - 187

7. Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system

   • Cristiano Matos
   • L. Rodrigues
   • J. Joaquim

   Original Research Article 08 February 2017 Pages: 188 - 194